Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Aug 28, 2022 9:51pm
225 Views
Post# 34925850

RE:RE:RE:No volume and no liquidity

RE:RE:RE:No volume and no liquidityWith Tigris results " greatly exceeding expectations" in a Phase 3 " Confirmatory" Trial and with DIMI approval " a when not if" event, and with the EAA ( the key to solving the Sepsis cunnundrum, see precision Medicine) already FDA approved, and with SAMI closing some big deals with key customers, and already FDA approved, and with mounting real world evidence on PMX, and with two leading experts on board, and with > 200,000 safe uses worldwide, and with Sepsis being a giant and growing problem, and with an almost certain paradigm shift to Home Dialysis in our future...

... THIS IS ABOUT AS FAR AWAY AS YOU CAN GET FROM A ROULETTE WHEEL TYPE OF INVESTMENT !

Jus sayin

MM 
<< Previous
Bullboard Posts
Next >>